Literature DB >> 24148223

Enabling autologous human liver regeneration with differentiated adipocyte stem cells.

Dan Xu1, Toshihiko Nishimura, Ming Zheng, Manhong Wu, Hua Su, Noboru Sato, Gordon Lee, Sara Michie, Jeffrey Glenn, Gary Peltz.   

Abstract

We developed a novel method for differentiating adipocyte-derived stem cells (ASCs) into hepatocyte-like cells (iHeps). ASCs are cultured as spherical cellular aggregates and are then induced by culture in chemically defined media for a short time period to differentiate into spherical culture iHeps (SCi-Heps). SCi-Heps have many of the in vitro functional properties of mature hepatocytes, and they can stably reconstitute functioning human liver in vivo in a murine model system. Implantation studies demonstrate that SCi-Heps have a very low malignant potential. All human liver regenerative procedures, including ultrasound-guided direct liver implantation, are scalable and appropriate for human clinical use. These methods can be used to achieve the major promise of regenerative medicine. It may now be possible to regenerate human liver using autologous stem cells obtained from a readily accessible tissue.

Entities:  

Mesh:

Year:  2013        PMID: 24148223     DOI: 10.3727/096368913X673432

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  10 in total

Review 1.  Adipose Tissue-Derived Stem Cells in Regenerative Medicine.

Authors:  Laura Frese; Petra E Dijkman; Simon P Hoerstrup
Journal:  Transfus Med Hemother       Date:  2016-07-26       Impact factor: 3.747

Review 2.  Assessing the therapeutic potential of lab-made hepatocytes.

Authors:  Milad Rezvani; Andrew A Grimm; Holger Willenbring
Journal:  Hepatology       Date:  2016-05-26       Impact factor: 17.425

Review 3.  Clinical Application of Induced Hepatocyte-like Cells Produced from Mesenchymal Stromal Cells: A Literature Review.

Authors:  Yanina Bogliotti; Mark Vander Roest; Aras N Mattis; Robert G Gish; Gary Peltz; Robin Anwyl; Salah Kivlighn; Eric R Schuur
Journal:  Cells       Date:  2022-06-22       Impact factor: 7.666

Review 4.  Emerging advancements in liver regeneration and organogenesis as tools for liver replacement.

Authors:  Stacey S Huppert; Kathleen M Campbell
Journal:  Curr Opin Organ Transplant       Date:  2016-12       Impact factor: 2.640

5.  Hypoxia enhances angiogenesis in an adipose-derived stromal cell/endothelial cell co-culture 3D gel model.

Authors:  Qiang Xie; Jing Xie; Juan Zhong; Xiangzhu Cun; Shiyu Lin; Yunfeng Lin; Xiaoxiao Cai
Journal:  Cell Prolif       Date:  2016-03-21       Impact factor: 6.831

6.  Rapid and high-efficiency generation of mature functional hepatocyte-like cells from adipose-derived stem cells by a three-step protocol.

Authors:  Fen Xu; Junli Liu; Jie Deng; Xiaolei Chen; Yuan Wang; Pengchao Xu; Lin Cheng; Yanli Fu; Fuyi Cheng; Yunqi Yao; Yujing Zhang; Meijuan Huang; Dechao Yu; Yuquan Wei; Hongxin Deng
Journal:  Stem Cell Res Ther       Date:  2015-10-05       Impact factor: 6.832

7.  Activation of Wnt/β-catenin signalling via GSK3 inhibitors direct differentiation of human adipose stem cells into functional hepatocytes.

Authors:  Jieqiong Huang; Xinyue Guo; Weihong Li; Haiyan Zhang
Journal:  Sci Rep       Date:  2017-01-17       Impact factor: 4.379

Review 8.  Stem cell therapy and tissue engineering strategies using cell aggregates and decellularized scaffolds for the rescue of liver failure.

Authors:  Jiabin Zhang; Hon Fai Chan; Haixia Wang; Dan Shao; Yu Tao; Mingqiang Li
Journal:  J Tissue Eng       Date:  2021-02-01       Impact factor: 7.813

Review 9.  Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives.

Authors:  Yanlei Yang; Robert Chunhua Zhao; Fengchun Zhang
Journal:  Front Cell Dev Biol       Date:  2022-07-18

10.  Fialuridine induces acute liver failure in chimeric TK-NOG mice: a model for detecting hepatic drug toxicity prior to human testing.

Authors:  Dan Xu; Toshi Nishimura; Sachiko Nishimura; Haili Zhang; Ming Zheng; Ying-Ying Guo; Marylin Masek; Sara A Michie; Jeffrey Glenn; Gary Peltz
Journal:  PLoS Med       Date:  2014-04-15       Impact factor: 11.069

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.